The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different

Journal of Virology

Volumn 79, Issue 1, 2005, Pages 289-298

  Lang, Susanne I ^a,b   Boelz, Stephanie ^a   Stroh Dege, Alexandra Y ^a   Rommelaere, Jean ^a   Dinsart, Christiane ^a   Cornelis, Jan J ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Molecular Medicine Partnership Unit   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA EXTRACTION; DNA REPLICATION; FIBROBLAST; GENE AMPLIFICATION; GENE EXPRESSION; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS STRAIN; WILD TYPE;

ANIMALS; CAPSID PROTEINS; CELL LINE; GENETIC VECTORS; HUMANS; MICE; MINUTE VIRUS OF MICE; PLAQUE ASSAY; PLASMIDS; RECOMBINATION, GENETIC; TRANSFECTION; VIRION; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 10644233763     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.1.289-298.2005     Document Type: Article

References (44)

1. Agbandje-McKenna, M., A. L. Llamas-Saiz, F. Wang, P. Tattersall, and M. G. Rossmann. 1998. Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure 6:1369-1381.
2. Ball-Goodrich, L. J., and P. Tattersall. 1992. Two amino acid substitutions within the capsid are coordinately required for acquisition of fibrotropism by the lymphotropic strain of minute virus of mice. J. Virol. 66:3415-3423.
3. Bodendorf, U., C. Cziepluch, J.-C. Jauniaux, J. Rommelaere, and N. Salomé. 1999. Nuclear export factor CRM1 interacts with nonstructural proteins NS2 of parvovirus minute virus of mice. J. Virol. 73:7769-7779.
4. Brandenburger, A., E. Coessens, K. El Bakkouri, and T. Velu. 1999. Influence of sequence and size of DNA on packaging efficiency of parvovirus MVM-based vectors. Hum. Gene Ther. 10:1229-1238.
5. Brockhaus, K., S. Plaza, D. J. Pintel, J. Rommelaere, and N. Salome. 1997. Nonstructural proteins NS2 of minute virus of mice associate in vivo with 14-3-3 protein family members. J. Virol. 70:7527-7534.
6. Caillet-Fauquet, P., M. Perros, A. Brandenburger, P. Spegelaere, and J. Rommelaere. 1990. Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO J. 9:2989-2995.
7. Chapman, M. S., and M. G. Rossmann. 1995. Single-stranded DNA-protein interactions in canine parvovirus. Structure 3:151-162.
8. Chen, Y. Q., F. deForesta, J. Hertoghs, B. L. Avalosse, J. J. Cornelis, and J. Rommelaere. 1986. Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H-1. Cancer Res. 46:3574-3579.
9. Cornelis, J. J., P. Becquart, N. Duponchel, N. Salome, B. L. Avalosse, M. Namba, and J. Rommelaere. 1988. Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvovirus H-1 and minute virus of mice. J. Virol. 62:1679-1686.
10. Dupont, F., L. Tenenbaum, L. P. Guo, P. Spegelaere, M. Zeicher, and J. Rommelaere. 1994. Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein. J. Virol. 68:1397-1407.
11. Engers, H. D., J. A. Louis, R. H. Zubler, and B. Hirt. 1981. Inhibition of T cell-mediated functions by MVM(i), a parrovirus closely related to minute virus of mice. J. Immunol. 127:2280-2285.
12. Giese, N. A., Z. Raykov, L. DeMartino, A. Vecchi, S. Sozzani, C. Dinsart, J. J. Cornelis, and J. Rommelaere. 2002. Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice. Cancer Gene Ther. 9:432-442.
13. Grimm, D., M. A. Kay, and J. A. Kleinschmidt. 2003. Helper-virus-free, optically controllable, and two plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol. Ther. 7:839-850.
14. Haag, A., J. Kestler, P. Menten, J. Van Damme, J. Rommelaere, C. Dinsart, and J. J. Cornelis. 2000. High efficient transduction of cytokines to human tumor cells by means of autonomous parvovirus vectors and their antitumor effect in nude mice. Hum. Gene Ther. 11:597-609.
15. Hansen, J., K. Qing, H.-J. Kwon, C. Mah, and A. Srivastava. 2000. Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J. Virol. 74:992-996.
16. Jacoby, R. O., L. J. Ball-Goodrich, D. G. Besselsen, M. D. McKisic, L. K. Riley, and A. L. Smith. 1996. Rodent parvovirus infections. Lab. Anim. Sci. 46:370-380.
17. Kestler, J., B. Neeb, S. Struyf, J. Van Damme, S. F. Cotmore, A. D'Abramo, P. Tattersall, J. Rommelaere, C. Dinsart, and J. J. Cornelis. 1999. cis requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses. Hum. Gene Ther. 10:1619-1632.
18. Li, X., and S. L. Rhode III. 1990. Mutation of lysine 405 to serine in the parvovirus H-1 NS1 abolishes its functions of viral DNA replication, late promoter trans activation, and cytotoxicity. J. Virol. 64:4654-4660.
19. Linser, P., H. Bruning, and R. W. Armentrout. 1977. Specific binding sites for a parvovirus, minute virus of mice, on cultured mouse cells. J. Virol. 24:211-221.
20. Linser, P., H. Bruning, and R. W. Armentrout. 1979. Uptake of minute virus of mice into cultured rodent cells. J. Virol. 31:537-545.
21. Maroto, B., J. C. Ramirez, and J. M. Almendral. 2000. Phosphorylation status of the parvovirus minute virus of mice particle: mapping and biological relevance of the major phosphorylation sites. J. Virol. 74:10892-10902.
22. Maxwell, I. H., F. Maxwell, S. L. Rhode III, J. Corsini, and J. O. Carlson. 1993. Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells. Hum. Gene Ther. 4:441-450.
23. Maxwell, I. H., K. L. Terrell, and F. Maxwell. 2002. Autonomous parvovirus vectors. Methods 28:168-181.
24. Ozawa, K., J. Ayub, S. Kajigaya, T. Shimada, and N. Young. 1988. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J. Virol. 62:2884-2889.
25. Palmer, G. A., and P. Tattersall. 2000. Autonomous parvoviruses as gene transfer vehicles. Contrib. Microbiol. 4:178-202.
26. Paradiso, P. R. 1981. Infectious process of the parvovirus H-1: correlation of protein content, particle density, and viral infectivity. J. Virol. 39:800-807.
27. Peterson, J. L., R. M. K. Dale, R. Karess, D. Leonard, and D. C. Ward. 1978. Comparison of parvovirus structural proteins: evidence for post-translational modification, p. 431-445. In D.C. Ward and P. Tattersall (ed.), Replication of mammalian parvoviruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
28. Previsani, N., S. Fontana, B. Hirt, and P. Beard. 1997. Growth of the parvovirus minute virus of mice MVMP3 in EL4 lymphocytes is restricted after cell entry and before viral DNA amplification: cell-specific differences in virus uncoating in vitro. J. Virol. 71:7769-7780.
29. Rayet, B., J. A. Lopez-Guerrero, J. Rommelaere, and C. Dinsart. 1998. Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha signalling pathway. J. Virol. 72:8893-8903.
30. Rhode, S. L., III. 1976. Replication process of the parvovirus H-1. V. Isolation and characterization of temperature-sensitive H-1 mutants defective in progeny DNA synthesis. J. Virol. 17:659-667.
31. Rhode, S. L., III. 1987. Construction of a genetic switch for inducible transactivation of gene expression in eucaryotic cells. J. Virol. 61:1148-1156.
32. Richards, R., P. Linser, and R. W. Armentrout. 1977. Kinetics of assembly of a parvovirus, minute virus of mice, in synchronized rat brain cells. J. Virol. 22:778-793.
33. Rommelaere, J., and J. J. Cornelis. 2001. Autonomous parvoviruses. Monogr. Virol. 22:100-129.
34. Russell, S. J., A. Brandenburger, C. L. Flemming, M. K. L. Collins, and J. Rommelaere. 1992. Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J. Virol. 66:2821-2828.
35. Santarén, J. F., J. C. Ramírez, and J. M. Almendral. 1993. Protein species of the parvovirus minute virus of mice strain MVMp: involvement of phosphorylated VP-2 subtypes in viral morphogenesis. J. Virol. 67:5126-5138.
36. Tattersall, P. 1972. Replication of the parvovirus MVM. I. Dependence of virus multiplication and plaque formation on cell growth. J. Virol. 10:586-590.
37. Tattersall, P., and J. Bratton. 1983. Reciprocal productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice. J. Virol. 46:944-955.
38. Tijssen, P., J. Bergeron, R. Dubuc, and B. Hébert. 1995. Minor genetic changes among porcine parvovirus groups are responsible for major distinguishing biological properties. Semin. Virol. 6:319-328.
39. Truyen, U., and C. R. Parrish. 1995. The evolution and control of parvovirus host ranges. Semin. Virol. 6:311-317.
40. Tullis, G. E., L. R. Burger, and D. J. Pintel. 1993. The minor capsid protein VPl of the autonomous parvovirus minute virus of mice is dispensable for encapsidation of progeny single-stranded DNA but is required for infectivity. J. Virol. 67:131-141.
41. Wetzel, K., P. Menten, G. Opdenakker, J. Van Damme, H. J. Grone, N. Giese, A. Vecchi, S. Sozzani, J. J. Cornelios, J. Rommelaere, and C. Dinsart. 2001. Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts. J. Gene Med. 3:326-337.
42. Wrzesinski, C., L. Tesfay, N. Salome, J. C. Jauniaux, J. Rommelaere, J. J. Cornelis, and C. Dinsart. 2003. Chimeric and pseudotyped parvoviruses minimize the contamination of recombinant stocks with replication-competent viruses and identify a DNA sequence that restricts parvovirus H-1 in mouse cells. J. Virol. 77:3851-3858.
43. Zadori, Z., J. Szelei, M. C. Lacoste, Y. Li, S. Gariépy, P. Raymond, M. Allaire, I. R. Nabi, and P. Tijssen. 2001. A viral phospholipase A2 is required for parvovirus infectivity. Dev. Cell 1:291-302.
44. Zolotukhin, S., B. J. Byrne, E. Mason, I. Zolotukhin, M. Potter, K. Chesnut, C. Summerford, R. J. Samulski, and N. Muzyczka. 1999. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6:973-985.